167
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Risk of Anemia in Patients with Newly Identified Chronic Kidney Disease – A Population-Based Cohort Study

ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 953-962 | Published online: 11 Sep 2020

References

  • Babitt JL, Lin HY. Mechanisms of Anemia in CKD. J Am Soc Nephrol. 2012;23(10):1631–1634. doi:10.1681/ASN.201111107822935483
  • Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–2047. doi:10.1681/ASN.200510108516738019
  • Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology. 2009;14(2):240–246. doi:10.1111/j.1440-1797.2008.01065.x19207866
  • Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010;17(4):293–301. doi:10.1053/j.ackd.2010.03.01020610356
  • Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the third national health and nutrition examination survey (19881994). Arch Intern Med. 2002;162(12):1401–1408. doi:10.1001/archinte.162.12.140112076240
  • Kohagura K, Tomiyama N, Kinjo K, Takishita S, Iseki K. Prevalence of anemia according to stage of chronic kidney disease in a large screening cohort of Japanese. Clin Exp Nephrol. 2009;13(6):614–620. doi:10.1007/s10157-009-0197-z19526304
  • Ryu SR, Park SK, Jung JY, et al. The prevalence and management of anemia in chronic kidney disease patients: result from the korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD). J Korean Med Sci. 2017;32(2):249–256. doi:10.3346/jkms.2017.32.2.24928049235
  • McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20(9):1501–1510. doi:10.1185/030079904X276315383200
  • Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943. doi:10.1371/journal.pone.008494324392162
  • St Peter WL, Guo H, Kabadi S, et al. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States. BMC Nephrol. 2018;19(1):67. doi:10.1186/s12882-018-0861-129544446
  • Li Y, Shi H, Wang WM, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study. Medicine. 2016;95(24):e3872. doi:10.1097/MD.000000000000387227310973
  • Schmidt M, Pedersen L, Sorensen HT. The danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133–138. doi:10.2147/CLEP.S1790121487452
  • Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
  • Pottegard A, Schmidt SAJ, Wallach-Kildemoes H, Sorensen HT, Hallas J, Schmidt M. Data resource profile: the danish national prescription registry. Int J Epidemiol. 2017;46(3):798–798f. doi:10.1093/ije/dyw21327789670
  • Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;(3):1–150.
  • Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–1750. doi:10.1182/blood-2005-07-304616189263
  • National Cancer Institute NIoH. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017;3 Available from:  https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed March 1, 2020
  • Rodgers GM 3rd, Becker PS, Blinder M, et al. Cancer- and chemotherapy-induced anemia. J Nat Comprehensive Cancer Network. 2012;10(5):628–653. doi:10.6004/jnccn.2012.0064
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
  • Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based danish national registry of patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-8321619668
  • Lin DY, Wei LJ. The robust inference for the cox proportional hazards model. J Am Stat Assoc. 1989;84(408):1074–1078. doi:10.1080/01621459.1989.10478874
  • Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5):615–625. doi:10.1097/01.ede.0000135174.63482.4315308962